Breaking News
News & Analysis

Intel's Big Data to Fight Parkinson's Disease

Partnership with Michael J. Fox Foundation sends patients home with wearables
8/14/2014 10:30 AM EDT
6 comments
NO RATINGS
1 saves
More Related Links
View Comments: Threaded | Newest First | Oldest First
Jessica Lipsky
User Rank
Author
How to add in Basis
Jessica Lipsky   8/14/2014 11:02:40 AM
NO RATINGS
Although Intel said the smartwatch was not its recently acquired Basis sleep/motion tracker, the company said it's looking on ways to integrate Basis into future programs. I'm surprised they didn't conduct this study with Basis in the first place.

3D Guy
User Rank
Manager
Andy Grove?
3D Guy   8/14/2014 1:22:00 PM
NO RATINGS
Andy Grove, who has Parkinson's, has been driving treatment for Parkinson's around the industry... glad to see Intel doing its bit to help his cause.  

goafrit
User Rank
Manager
Re: Andy Grove?
goafrit   8/15/2014 8:06:46 PM
NO RATINGS
>> Andy Grove, who has Parkinson's, has been driving treatment for Parkinson's around the industry

That is news to me that Andy Grove has Parkinson. This may be a better Moore's Law to crack. Intel should spare nothing to get this issue solved. Getting big data into the domain of chip design sounds interesting. Intel has an opportunity here to reshape this industry that has been software driven.

rick merritt
User Rank
Author
Cross our fingers
rick merritt   8/14/2014 5:07:24 PM
NO RATINGS
Gathering data is one thing our electroncis can do so well...finding patterns that lead to better understanding and treatment is the hard job methinks.

resistion
User Rank
CEO
data is not enough
resistion   8/14/2014 9:48:10 PM
NO RATINGS
Industry has to make use of the data and provide the solution. But they must feel it costs too much to go through all the data. Otherwise why the need for hard sell?

DrQuine
User Rank
CEO
Big Data and Personalized Medicine
DrQuine   8/17/2014 6:16:57 PM
NO RATINGS
Traditional treatment studies take a large population of patients and compare the success of a new treatment against a placebo (or the previous treatment). This makes perfect sense if everyone were identical. However, cancer research is showing that individual differences may be very meaningful.

If "ONLY" 5% of the subjects respond to a particular treatment, it might be that the treatment is not very effective. However, it might also mean that a particular genotype of the population (5% of the group) is completely cured by the treatment and other genotypes are not.

Big data and genetic analysis provide a unique opportunity to conduct studies to identify if there are subsets of the population that do respond well to a particular treatment. The day is coming when treatments will be customized to our genotype.  It is already happening for some cancers.

August Cartoon Caption Winner!
August Cartoon Caption Winner!
"All the King's horses and all the KIng's men gave up on Humpty, so they handed the problem off to Engineering."
5 comments
Top Comments of the Week
Like Us on Facebook

Datasheets.com Parts Search

185 million searchable parts
(please enter a part number or hit search to begin)
EE Times on Twitter
EE Times Twitter Feed
Flash Poll
Radio
LATEST ARCHIVED BROADCAST
David Patterson, known for his pioneering research that led to RAID, clusters and more, is part of a team at UC Berkeley that recently made its RISC-V processor architecture an open source hardware offering. We talk with Patterson and one of his colleagues behind the effort about the opportunities they see, what new kinds of designs they hope to enable and what it means for today’s commercial processor giants such as Intel, ARM and Imagination Technologies.